{"DataElement":{"publicId":"14569128","version":"1","preferredName":"Adverse Event Domain ASTCT Consensus Grading System for Cytokine Release Syndrome Assessment Grade","preferredDefinition":"The assessment grades of severity of cytokine release syndrome done as per ASTCT consensus grading system guidelines.","longName":"AE_AETOXGR_CRSASTCT","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"14569127","version":"1","preferredName":"Adverse Event Domain ASTCT Consensus Grading System for Cytokine Release Syndrome Assessment","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to an adverse event.:A consensus system for grading cytokine release syndrome (CRS) associated with chimeric antigen receptor (CAR) T-cell therapy. It was developed by the American Society for Transplantation and Cellular Therapy in June 2018. It consists of 5 grades determined by the degree of intervention administered to a patient in order to treat fever, hypotension, and/or hypoxia._The final result of a determination of the value, significance, or extent of.","longName":"2514626v1.00:14569126v1.00","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2514626","version":"1","preferredName":"Adverse Event Submission Domain","preferredDefinition":"No Value Exists","longName":"C49562","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adverse Event Domain","conceptCode":"C49562","definition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to an adverse event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1BB1AAFE-FB2D-4FE3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-08-23","modifiedBy":"ONEDATA","dateModified":"2006-08-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"14569126","version":"1","preferredName":"ASTCT Consensus Grading System for Cytokine Release Syndrome Assessment","preferredDefinition":"A consensus system for grading cytokine release syndrome (CRS) associated with chimeric antigen receptor (CAR) T-cell therapy. It was developed by the American Society for Transplantation and Cellular Therapy in June 2018. It consists of 5 grades determined by the degree of intervention administered to a patient in order to treat fever, hypotension, and/or hypoxia._The final result of a determination of the value, significance, or extent of.","longName":"C201867:C25217","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ASTCT Consensus Grading System for Cytokine Release Syndrome","conceptCode":"C201867","definition":"A consensus system for grading cytokine release syndrome (CRS) associated with chimeric antigen receptor (CAR) T-cell therapy. It was developed by the American Society for Transplantation and Cellular Therapy in June 2018. It consists of 5 grades determined by the degree of intervention administered to a patient in order to treat fever, hypotension, and/or hypoxia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"087AE205-E913-2C9E-E063-731AD00A4C4A","latestVersionIndicator":"Yes","beginDate":"2023-10-24","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-10-24","modifiedBy":"MMADDINENI","dateModified":"2023-10-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"087AE205-E914-2C9E-E063-731AD00A4C4A","latestVersionIndicator":"Yes","beginDate":"2023-10-24","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-10-24","modifiedBy":"MMADDINENI","dateModified":"2024-01-11","changeDescription":null,"administrativeNotes":"10/24/2023: Created DEC(CADSR002962)-MM","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"14569122","version":"1","preferredName":"ASTCT Consensus Grading System for Cytokine Release Syndrome Grade","preferredDefinition":"A consensus system for grading cytokine release syndrome (CRS) associated with chimeric antigen receptor (CAR) T-cell therapy. It was developed by the American Society for Transplantation and Cellular Therapy in June 2018. It consists of 5 grades determined by the degree of intervention administered to a patient in order to treat fever, hypotension, and/or hypoxia._A position on a scale of intensity or amount or quality.","longName":"14569122v1.00","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"1","valueDescription":null,"ValueMeaning":{"publicId":"14569123","version":"1","preferredName":"ASTCT CRS Grade 1","longName":"14569123v1.00","preferredDefinition":"Fever (greater than or equal to 38C) with or without constitutional symptoms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ASTCT CRS Grade 1","conceptCode":"C201985","definition":"Fever (greater than or equal to 38C) with or without constitutional symptoms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"087AD2FE-F31D-2A5D-E063-731AD00A0FDF","latestVersionIndicator":"Yes","beginDate":"2023-10-24","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-10-24","modifiedBy":"KUMMEROA","dateModified":"2023-11-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"087AD2FE-F320-2A5D-E063-731AD00A0FDF","beginDate":"2023-10-24","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-10-24","modifiedBy":"MMADDINENI","dateModified":"2023-10-24","deletedIndicator":"No"},{"value":"3","valueDescription":null,"ValueMeaning":{"publicId":"14569124","version":"1","preferredName":"ASTCT CRS Grade 3","longName":"14569124v1.00","preferredDefinition":"Fever (greater than or equal to 38C) with hypotension requiring 1 vasopressor with or without vasopressin and/or hypoxia requiring high-flow nasal cannula (greater than 6 L/minute), face mask, nonrebreather mask, or Venturi mask not attributable to any other cause.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ASTCT CRS Grade 3","conceptCode":"C201987","definition":"Fever (greater than or equal to 38C) with hypotension requiring 1 vasopressor with or without vasopressin and/or hypoxia requiring high-flow nasal cannula (greater than 6 L/minute), face mask, nonrebreather mask, or Venturi mask not attributable to any other cause.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"087AD2FE-F31E-2A5D-E063-731AD00A0FDF","latestVersionIndicator":"Yes","beginDate":"2023-10-24","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-10-24","modifiedBy":"KUMMEROA","dateModified":"2023-11-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"087AD2FE-F322-2A5D-E063-731AD00A0FDF","beginDate":"2023-10-24","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-10-24","modifiedBy":"MMADDINENI","dateModified":"2023-10-24","deletedIndicator":"No"},{"value":"5","valueDescription":null,"ValueMeaning":{"publicId":"14569125","version":"1","preferredName":"ASTCT CRS Grade 5","longName":"14569125v1.00","preferredDefinition":"Death due to cytokine release syndrome (CRS) in which another cause is not the principal factor leading to this outcome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ASTCT CRS Grade 5","conceptCode":"C201989","definition":"Death due to cytokine release syndrome (CRS) in which another cause is not the principal factor leading to this outcome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"087AD2FE-F31F-2A5D-E063-731AD00A0FDF","latestVersionIndicator":"Yes","beginDate":"2023-10-24","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-10-24","modifiedBy":"KUMMEROA","dateModified":"2023-11-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"087AD2FE-F324-2A5D-E063-731AD00A0FDF","beginDate":"2023-10-24","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-10-24","modifiedBy":"MMADDINENI","dateModified":"2023-10-24","deletedIndicator":"No"},{"value":"2","valueDescription":null,"ValueMeaning":{"publicId":"14596812","version":"1","preferredName":"ASTCT CRS Grade 2","longName":"14596812v1.00","preferredDefinition":"Fever (greater than or equal to 38C) with hypotension not requiring vasopressors and/or hypoxia requiring the use of oxygen delivered by low-flow nasal cannula (less than or equal to 6 L/minute) or blow-by delivery.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ASTCT CRS Grade 2","conceptCode":"C201986","definition":"Fever (greater than or equal to 38C) with hypotension not requiring vasopressors and/or hypoxia requiring the use of oxygen delivered by low-flow nasal cannula (less than or equal to 6 L/minute) or blow-by delivery.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"094413E6-A454-4481-E063-731AD00A8CA6","latestVersionIndicator":"Yes","beginDate":"2023-11-03","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-03","modifiedBy":"KUMMEROA","dateModified":"2023-11-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"094413E6-A456-4481-E063-731AD00A8CA6","beginDate":"2023-11-03","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-03","modifiedBy":"KUMMEROA","dateModified":"2023-11-03","deletedIndicator":"No"},{"value":"4","valueDescription":null,"ValueMeaning":{"publicId":"14596813","version":"1","preferredName":"ASTCT CRS Grade 4","longName":"14596813v1.00","preferredDefinition":"Fever (greater than or equal to 38C) with hypotension requiring multiple vasopressors (excluding vasopressin) and/or hypoxia requiring positive pressure (e.g., continuous positive airway pressure (CPAP), bilevel positive airway pressure (BiPAP), intubation, mechanical ventilation) not attributable to any other cause.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ASTCT CRS Grade 4","conceptCode":"C201988","definition":"Fever (greater than or equal to 38C) with hypotension requiring multiple vasopressors (excluding vasopressin) and/or hypoxia requiring positive pressure (e.g., continuous positive airway pressure (CPAP), bilevel positive airway pressure (BiPAP), intubation, mechanical ventilation) not attributable to any other cause.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"094413E6-A455-4481-E063-731AD00A8CA6","latestVersionIndicator":"Yes","beginDate":"2023-11-03","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-03","modifiedBy":"KUMMEROA","dateModified":"2023-11-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"094413E6-A457-4481-E063-731AD00A8CA6","beginDate":"2023-11-03","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-03","modifiedBy":"KUMMEROA","dateModified":"2023-11-03","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"14569121","version":"1","preferredName":"ASTCT Consensus Grading System for Cytokine Release Syndrome Grade","preferredDefinition":"A consensus system for grading cytokine release syndrome (CRS) associated with chimeric antigen receptor (CAR) T-cell therapy. It was developed by the American Society for Transplantation and Cellular Therapy in June 2018. It consists of 5 grades determined by the degree of intervention administered to a patient in order to treat fever, hypotension, and/or hypoxia._A position on a scale of intensity or amount or quality.","longName":"14569121v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ASTCT Consensus Grading System for Cytokine Release Syndrome","conceptCode":"C201867","definition":"A consensus system for grading cytokine release syndrome (CRS) associated with chimeric antigen receptor (CAR) T-cell therapy. It was developed by the American Society for Transplantation and Cellular Therapy in June 2018. It consists of 5 grades determined by the degree of intervention administered to a patient in order to treat fever, hypotension, and/or hypoxia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Grade","conceptCode":"C48309","definition":"A position on a scale of intensity or amount or quality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"087AC755-B75C-1FB9-E063-731AD00AB863","latestVersionIndicator":"Yes","beginDate":"2023-10-24","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-10-24","modifiedBy":"MMADDINENI","dateModified":"2023-10-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"087AC755-B75D-1FB9-E063-731AD00AB863","latestVersionIndicator":"Yes","beginDate":"2023-10-24","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-10-24","modifiedBy":"MMADDINENI","dateModified":"2024-01-11","changeDescription":null,"administrativeNotes":"10/24/2023: Created VD(CADSR0002962)-MM","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"What is the Cytokine Release Syndrome grade per ASTCT guidelines?","url":null,"context":"COG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"ASTCT CRS grade","url":null,"context":"COG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"087AFD11-B18B-3088-E063-731AD00A1ED6","latestVersionIndicator":"Yes","beginDate":"2023-10-24","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-10-24","modifiedBy":"MMADDINENI","dateModified":"2024-01-11","changeDescription":null,"administrativeNotes":"12023.11.12 AQT added per ticket request CADSR0003061. ak 0/24/2023: Created CDE(CADSR0002962)-MM","unresolvedIssues":null,"deletedIndicator":"No"}}